BANK OF AMERICA CORP /DE/ - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,862,697
-22.9%
587,057
-11.3%
0.00%0.0%
Q2 2023$8,897,333
-45.6%
662,004
-32.9%
0.00%
-50.0%
Q1 2023$16,345,891
-4.1%
985,880
+7.6%
0.00%0.0%
Q4 2022$17,045,896
+179.0%
916,446
+92.4%
0.00%
+100.0%
Q3 2022$6,110,000
+625.7%
476,259
+296.3%
0.00%
Q2 2022$842,000
-59.9%
120,182
-52.6%
0.00%
Q1 2022$2,100,000
-10.3%
253,326
-26.8%
0.00%
Q4 2021$2,342,000
+248.5%
345,867
+173.0%
0.00%
Q3 2021$672,000
-36.4%
126,670
-31.1%
0.00%
Q2 2021$1,056,000
+12.1%
183,752
-10.1%
0.00%
Q1 2021$942,000
+16.9%
204,353
-15.3%
0.00%
Q4 2020$806,000
-0.5%
241,185
-11.6%
0.00%
Q3 2020$810,000
+37.3%
272,727
+113.8%
0.00%
Q2 2020$590,000
+22.9%
127,573
+2.3%
0.00%
Q1 2020$480,000
-11.1%
124,685
-13.4%
0.00%
Q4 2019$540,000
-42.4%
143,969
-18.4%
0.00%
Q3 2019$937,000
+15.4%
176,476
-16.6%
0.00%
Q2 2019$812,000
+549.6%
211,545
+761.7%
0.00%
Q1 2019$125,000
+54.3%
24,550
-41.0%
0.00%
Q4 2018$81,000
+80.0%
41,627
+251.2%
0.00%
Q3 2018$45,000
+164.7%
11,854
+117.2%
0.00%
Q2 2018$17,000
-83.8%
5,457
-87.6%
0.00%
Q1 2018$105,000
+47.9%
44,126
+141.0%
0.00%
Q4 2017$71,000
+294.4%
18,311
+156.7%
0.00%
Q3 2017$18,000
+350.0%
7,132
+388.8%
0.00%
Q2 2017$4,000
+33.3%
1,4590.0%0.00%
Q1 2017$3,000
+50.0%
1,459
-21.6%
0.00%
Q4 2016$2,0000.0%1,860
+27.5%
0.00%
Q3 2016$2,000
-88.9%
1,459
-94.3%
0.00%
Q2 2016$18,000
+800.0%
25,643
+1657.6%
0.00%
Q1 2016$2,000
-94.9%
1,459
-90.7%
0.00%
Q4 2015$39,000
-78.1%
15,626
-73.7%
0.00%
Q3 2015$178,000
-55.1%
59,489
-37.9%
0.00%
Q2 2015$396,000
+42.4%
95,823
+49.1%
0.00%
Q1 2015$278,000
+9.9%
64,259
-24.6%
0.00%
Q4 2014$253,000
-2.7%
85,259
+8.8%
0.00%
Q3 2014$260,000
+36.1%
78,359
+4.0%
0.00%
Q2 2014$191,000
+377.5%
75,359
+328.2%
0.00%
Q1 2014$40,000
+48.1%
17,600
+29.9%
0.00%
Q4 2013$27,000
-59.7%
13,547
-38.7%
0.00%
Q3 2013$67,000
+235.0%
22,100
-0.1%
0.00%
Q2 2013$20,00022,1120.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders